Berenberg Bank Issues Positive Forecast for Reckitt Benckiser Group (LON:RKT) Stock Price

Key Points

• Berenberg Bank raised Reckitt Benckiser Group’s price target to GBX 5,382 from GBX 5,352 while maintaining a “hold” rating, implying roughly 0.88% downside from the prior close.
• Analyst sentiment is mixed but leans positive: MarketBeat reports a consensus “Moderate Buy” rating and an average target price of GBX 5,930.33, with targets ranging from GBX 5,400 to GBX 6,500.
• Reckitt shares opened at GBX 5,430, with a £34.42 billion market capitalization; insiders recently purchased shares, though insider ownership remains low at 0.44%.

Reckitt Benckiser Group (LON:RKT - Get Free Report) had its target price boosted by equities research analysts at Berenberg Bank from GBX 5,352 to GBX 5,382 in a research note issued to investors on Monday, Digital Look reports. The brokerage presently has a "hold" rating on the stock. Berenberg Bank's price target suggests a potential downside of 0.88% from the company's previous close.

Several other brokerages have also commented on RKT. Royal Bank Of Canada restated a "sector perform" rating and issued a GBX 6,200 price objective on shares of Reckitt Benckiser Group in a report on Wednesday, July 29th. JPMorgan Chase & Co. lifted their target price on shares of Reckitt Benckiser Group from GBX 5,800 to GBX 6,500 and gave the company an "overweight" rating in a research note on Tuesday, September 1st. Jefferies Financial Group reaffirmed a "buy" rating and set a GBX 5,900 target price on shares of Reckitt Benckiser Group in a research note on Wednesday, October 28th. Finally, Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and set a GBX 5,400 price target on shares of Reckitt Benckiser Group in a research report on Thursday, July 30th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of GBX 5,930.33.

Reckitt Benckiser Group Stock Performance

LON:RKT opened at GBX 5,430 on Monday. The stock has a market cap of £34.42 billion, a P/E ratio of 12.30, a price-to-earnings-growth ratio of 1.10 and a beta of 0.26. The firm's fifty day simple moving average is GBX 5,161.10 and its 200 day simple moving average is GBX 5,233.95. Reckitt Benckiser Group has a twelve month low of GBX 3,866 and a twelve month high of GBX 6,522.92. The company has a quick ratio of 0.46, a current ratio of 0.59 and a debt-to-equity ratio of 179.24.

Insider Activity at Reckitt Benckiser Group

In other news, insider Deborah Waterhouse purchased 152 shares of the company's stock in a transaction that occurred on Wednesday, August 26th. The shares were bought at an average cost of GBX 5,189 per share, for a total transaction of £7,887.28. Also, insider Gavin Patterson purchased 191 shares of Reckitt Benckiser Group stock in a transaction that occurred on Wednesday, August 26th. The stock was purchased at an average cost of GBX 5,183 per share, for a total transaction of £9,899.53. Insiders own 0.44% of the company's stock.

Reckitt Benckiser Group Company Profile

At Reckitt, we protect, heal and nurture. We are the company behind some of the world's best known and most trusted Health and Hygiene consumer brands. Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years. We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide. At Reckitt, we're all making a real difference to people all over the world, every day.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.